Mini Theta Burst TMS to Promote Brain Plasticity Indexed by fMRI

Mini Theta Burst TMS to Promote Brain Plasticity Indexed by fMRI
Recruiting
99 years or below
All
1 Location

Brief description of study

Non-invasive transcranial magnetic stimulation (TMS) is now FDA-approved for the treatment of major depressive disorder (MDD). However, there is growing evidence that the targeting strategy for delivering TMS treatment would yield superior clinical outcomes if it were more tailored to individual neuroanatomy. In this study, we plan to examine whether functional MRI-guided TMS might be more effective than traditional methods at temporarily influencing neural circuit communication. If this is true, future studies may utilize these methods to yield an even greater leap forward in promoting optimal clinical outcomes using full doses of TMS for treatment.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Major Depressive Disorder
  • Age: 99 years or below
  • Gender: All
Updated on 19 Feb 2024. Study ID: 825761

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.